MXCT Stock Analysis: Buy, Sell, or Hold?
MXCT - MaxCyte, Inc. Common Stock
$1.04
-0.05 (-4.59%)
▼
5d:
+23.33%
30d:
+27.56%
90d:
+44.52%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When MXCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: MXCT is 11.8% above its trading range ($0.93). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: MXCT is 11.8% above its trading range ($0.93). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: MXCT is currently trading at $1.04, which is considered extended relative to its 30-day fair value range of $0.78 to $0.93.
Technical Outlook: Technically, MXCT is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.16. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: MXCT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.11 (+295.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MXCT is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.16. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: MXCT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.11 (+295.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.78 -
$0.93
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+11.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 295.0% below Wall St target ($4.11)
Trading Range Analysis
30-Day Trading Range
$0.78 -
$0.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.78
Resistance Level
$1.16
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.18
Wall Street Target
$4.11
(+295.0%)
Revenue Growth (YoY)
-7.1%
Profit Margin
-121.2%
Share & Embed Analysis
Last updated: May 18, 2026 6:43 AM ET
Data refreshes hourly during market hours. Next update: 7:43 AM
Data refreshes hourly during market hours. Next update: 7:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MXCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Douglas J Swirsky
SELL
10142 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
